Periodic Reporting for period 1 - Sub-NK (Subcutaneous delivery of theranostic cell-based therapies)

Cancer immunotherapy has transformed cancer treatment, with natural killer (NK) cells showing particular promise due to their ability to selectively target and eliminate cancer cells. However, effective delivery of these therapeutic cells to tumor sites while maintaining their...